Literature DB >> 7295112

Encephalopathy in infants and children with chronic renal disease.

C M Foley, M S Polinsky, A B Gruskin, H J Baluarte, W D Grover.   

Abstract

The examination of five pediatric patients with encephalopathy secondary to chronic renal failure has indicated a stereotyped sequence of neurologic signs and symptoms including ataxia, loss of motor abilities, myoclonus, seizures, dementia, and bulbar dysfunction. Both the patients with CNS dysfunction and a control group selected for a similar degree of renal failure had increased levels of serum phosphate, alkaline phosphatase, and parathyroid hormone. Serial EEGs in the affected group revealed progressive slowing and an increase in paroxysmal features. No specific neuropathologic findings were noted in one patient.

Entities:  

Mesh:

Year:  1981        PMID: 7295112     DOI: 10.1001/archneur.1981.00510100084016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  High aluminium content of infant milk formulas.

Authors:  R Weintraub; G Hams; M Meerkin; A R Rosenberg
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

3.  Aluminum content of infant formulas used in Turkey.

Authors:  G Sahin; A Aydin; A Işimer; I Ozalp; S Duru
Journal:  Biol Trace Elem Res       Date:  1995-10       Impact factor: 3.738

4.  Cognitive functioning and school performance in children with renal failure.

Authors:  K W Lawry; B H Brouhard; R J Cunningham
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

Review 5.  Aluminum toxicity in childhood.

Authors:  A Sedman
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

6.  Feeding disorders and gastroesophageal reflux in infants with chronic renal failure.

Authors:  E J Ruley; G H Bock; B Kerzner; A W Abbott; M Majd; I Chatoor
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

7.  Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?

Authors:  David W Mudge; David W Johnson; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; Carolyn L van Eps; James J B Petrie
Journal:  BMC Nephrol       Date:  2011-05-13       Impact factor: 2.388

8.  Ferric citrate hydrate as a phosphate binder and risk of aluminum toxicity.

Authors:  Ajay Gupta
Journal:  Pharmaceuticals (Basel)       Date:  2014-09-26

Review 9.  Strategies for Phosphate Control in Patients With CKD.

Authors:  Fellype Carvalho Barreto; Daniela Veit Barreto; Ziad A Massy; Tilman B Drüeke
Journal:  Kidney Int Rep       Date:  2019-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.